Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | August 09, 2022 01:35pm

 

Gainers

  • Verona Pharma (NASDAQ:VRNA) stock moved upwards by 35.8% to $9.44 during Tuesday's regular session. As of 13:30 EST, this security is trading at a volume of 32.8 million shares, making up 35311.8% of its average full-day volume over the last 100 days. The company's market cap stands at $569.8 million. As per the press release, Q2 earnings came out today.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) stock increased by 34.8% to $1.21. As of 13:30 EST, this security is trading at a volume of 44.6 million shares, making up 54406.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $49.7 million.
  • Mersana Therapeutics (NASDAQ:MRSN) stock moved upwards by 31.99% to $6.93. Trading volume for this security as of 13:30 EST is 12.7 million, which is 1007.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $672.1 million. As per the news, the Q2 earnings report came out yesterday.
  • Graybug Vision (NASDAQ:GRAY) shares increased by 30.3% to $1.26. Graybug Vision's stock is trading at a volume of 10.9 million shares as of 13:30 EST. This is 3382.8% of its average full-day volume over the last 100 days. The company's market cap stands at $26.9 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares rose 25.34% to $4.55. The current volume of 11.5 million shares is 574.0% of Atara Biotherapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $424.9 million. The company's, Q2 earnings came out yesterday.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) stock moved upwards by 20.3% to $8.77. Trading volume for Phathom Pharmaceuticals's stock is 2.6 million as of 13:30 EST. This is 933.9% of its average full-day volume over the last 100 days. The company's market cap stands at $343.5 million.

Losers

  • Quanterix (NASDAQ:QTRX) shares fell 59.1% to $6.75 during Tuesday's regular session. As of 13:30 EST, Quanterix's stock is trading at a volume of 8.0 million, which is 2098.9% of its average full-day volume over the last 100 days. The company's market cap stands at $248.9 million. The company's, Q2 earnings came out yesterday.
  • Cormedix (NASDAQ:CRMD) shares fell 57.85% to $3.17. The current volume of 4.2 million shares is 912.6% of Cormedix's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $124.0 million.
  • Aytu BioPharma (NASDAQ:AYTU) stock decreased by 50.66% to $0.29. Trading volume for Aytu BioPharma's stock is 11.4 million as of 13:30 EST. This is 2331.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.0 million.
  • Endo International (NASDAQ:ENDP) shares fell 41.52% to $0.39. As of 13:30 EST, Endo International's stock is trading at a volume of 92.4 million, which is 189.1% of its average full-day volume over the last 100 days. The company's market cap stands at $91.8 million. The company's, Q2 earnings came out today.
  • DermTech (NASDAQ:DMTK) stock decreased by 34.1% to $5.56. The current volume of 1.7 million shares is 181.8% of DermTech's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $166.3 million. As per the news, the Q2 earnings report came out yesterday.
  • Novavax (NASDAQ:NVAX) stock declined by 30.98% to $39.52. Novavax's stock is trading at a volume of 22.6 million shares as of 13:30 EST. This is 314.5% of its average full-day volume over the last 100 days. The company's market cap stands at $3.0 billion. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATRA AYTU CRMD DMTK EFTR ENDP GRAY MRSN NVAX PHAT QTRX VRNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist